Invested: July 2020
Formed in 2020, InsituGen technology was developed at the University of Otago, led by Professor Alison Heather, a world-leading expert in the field of hormonal testing.
InsituGen’s first commercial products are focused in the horse racing industry. The intention is to then adapt this into a human kit to be supplying major codes as early as 2022. Looking beyond sports, Professor Heather is examining the potential for the technology to be used in a medical application to monitor hormone levels. This could potentially assist the process of regulating dosage of hormone inhibitors used in certain hormone sensitive cancers, including breast cancer.